Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 6/2010

01-11-2010

Neuro-ophthalmologic Complications and Manifestations of Upper and Lower Motor Neuron Facial Paresis

Authors: M. Tariq Bhatti, Jade S. Schiffman, Anastas F. Pass, Rosa A. Tang

Published in: Current Neurology and Neuroscience Reports | Issue 6/2010

Login to get access

Abstract

The facial nerve (cranial nerve VII) courses a long pathway beginning in the precentral gyrus and ending at the facial muscles, lacrimal and salivary glands, and structures of the inner ear. Lesions along this pathway, clinically divided into upper and lower motor neuron lesions, present with unique characteristics that assist the physician in identifying the lesion site. The sequelae particularly of peripheral CN VII palsies, may result in significant and chronic damage to the cornea that may be challenging for the physician and patient.
Literature
1.
Anderson CA, Sandberg E, Filley CM, et al.: One and one-half syndrome with supranuclear facial weakness: magnetic resonance imaging localization. Arch Neurol 1999, 56(12):1509–1511.CrossRefPubMed
2.
3.
Rahman I, Sadiq SA: Ophthalmic management of facial nerve palsy: a review. Surv Ophthalmol 2007, 52(2):121–144.CrossRefPubMed
4.
Razfar A, Afifi AM, Manders EK, et al.: Ocular outcomes after gold weight placement and facial nerve resection. Otolaryngol Head Neck Surg 2009, 140(1):82–85.CrossRefPubMed
5.
Hoffman WY: Reanimation of the paralyzed face. Otolaryngol Clin North Am 1992, 25(3):649–667.PubMed
6.
Conley J, May M: Perspectives in facial reanimation. In The Facial Nerve. edn 2. Edited by May M, Schaitkin BM. New York: Thieme Medical Publishers; 2000:551–570.
7.
van de Graaf RC, IJpma FF: Remarks on the early history of Bell’s palsy. Eur Arch Otorhinolaryngol 2008, 265(11):1433–1434.CrossRefPubMed
8.
9.
Devriese PP, Schumacher T, Scheide A, et al.: Incidence, prognosis and recovery of Bell’s palsy. A survey of about 1,000 patients (1974–1983). Clin Otolaryngol Allied Sci 1990, 15(1):15–27.CrossRefPubMed
10.
Hauser WA, Karnes WE, Annis J, Kurland LT: Incidence and prognosis of Bell’s palsy in the population of Rochester, Minnesota. Mayo Clin Proc 1971, 46(4):258–264.PubMed
11.
Adour KK, Byl FM, Hilsinger RL Jr, et al: The true nature of Bell’s palsy: analysis of 1,000 consecutive patients. Laryngoscope 1978, 88(5):787–801.PubMed
12.
Yanagihara N, Mori H, Kozawa T, et al.: Bell’s palsy. Nonrecurrent v recurrent and unilateral v bilateral. Arch Otolaryngol 1984, 110(6):374–377.PubMed
13.
Gilden D: Treatment of Bell’s palsy—the pendulum has swung back to steroids alone. Lancet Neurol 2008, 7(11):976–977.CrossRefPubMed
14.
House JW, Brackmann DE: Facial nerve grading system. Otolaryngol Head Neck Surg 1985, 93(2):146–147.PubMed
15.
Schaitkin BM, May M: Reporting recovery of facial function. In The Facial Nerve. edn 2. Edited by May M, Schaitkin BM. New York: Thieme Medical Publishers; 2000:275–294.
16.
de Ru JA, van Benthem PP, Hordijk GJ: Arguments favouring the pharmacotherapy of Bells’ palsy [in Dutch]. Ned Tijdschr Geneeskd 2005, 149(26):1454.PubMed
17.
Kang TS, Vrabec JT, Giddings N, Terris DJ: Facial nerve grading systems (1985–2002): beyond the House-Brackmann scale. Otol Neurotol 2002, 23(5):767–771.CrossRefPubMed
18.
Salinas RA, Alvarez G, Ferreira J: Corticosteroids for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2004, CD001942.
19.
Allen D, Dunn L: Aciclovir or valaciclovir for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2004, CD001869.
20.
Sullivan FM, Swan IR, Donnan PT, et al.: Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 2007, 357(16):1598–1607.CrossRefPubMed
21.
•• Engström M, Berg T, Stjernquist-Desatnik A, et al.: Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008, 7(11):993–1000. This study included 839 BP patients treated within 72 h of onset of symptoms in a double-blind protocol. It found that patients receiving prednisolone alone achieved a significantly shorter time to full recovery compared with those receiving combination therapy. At 6 months, full recovery was achieved in 71% (n = 150) of the prednisolone/placebo group (P < 0.003), 58% (n = 120) of the valacyclovir/placebo group (P < 0.0001), 72% (n = 149) of the prednisolone/valacyclovir group (P < 0.0001), and 62% (n = 127) of the double-placebo group (P < 0.0001). Further, use of antiviral treatment did not provide any additional benefit. CrossRefPubMed
22.
Minnerop M, Herbst M, Fimmers R, et al: Bell’s palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone. J Neurol 2008, 255(11):1726–1730.CrossRefPubMed
23.
Hato N, Yamada H, Kohno H, et al.: Valacyclovir and prednisolone treatment for Bell’s palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007, 28(3):408–413.CrossRefPubMed
24.
Kawaguchi K, Inamura H, Abe Y, et al: Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell’s palsy. Laryngoscope 2007, 117(1):147–156.CrossRefPubMed
25.
Yeo SG, Lee YC, Park DC, Cha CI: Acyclovir plus steroid vs steroid alone in the treatment of Bell’s palsy. Am J Otolaryngol 2008, 29(3):163–166.CrossRefPubMed
26.
• de Almeida JR, Al Khabori M, Guyatt GH, et al.: Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA 2009, 302(9):985–993. The authors performed a meta-analysis of 18 clinical trials totaling 2,786 patients with BP to determine the effect of corticosteroids and antiviral agents on the risk of unsatisfactory facial recovery. Corticosteroids were found to reduce the risk of an unsatisfactory recovery outcome, whereas antiviral agents were found to have no beneficial effect. The combination of corticosteroids and antiviral agents had a borderline effect in reducing the risk of an unsatisfactory recovery outcome. CrossRefPubMed
27.
• Goudakos JK, Markou KD: Corticosteroids vs corticosteroids plus antiviral agents in the treatment of Bell palsy: a systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg 2009, 135(6):558–564. Five randomized controlled studies published from 1996 to 2007 totaling 738 patients were analyzed. The authors found no benefit from adding an antiviral agent to corticosteroids in increasing the recovery rate of FNP in patients with BP. CrossRefPubMed
28.
Hato N, Matsumoto S, Kisaki H, et al.: Efficacy of early treatment of Bell’s palsy with oral acyclovir and prednisolone. Otol Neurotol 2003, 24(6):948–951.CrossRefPubMed
29.
Gilden DH, Tyler KL: Bell’s palsy—is glucocorticoid treatment enough? N Engl J Med 2007, 357(16):1653–1655.CrossRefPubMed
30.
Murakami S, Mizobuchi M, Nakashiro Y, et al.: Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996, 124(1 Pt 1):27–30.PubMed
31.
Madhok V, Falk G, Fahey T, Sullivan FM: Prescribe prednisolone alone for Bell’s palsy diagnosed within 72 h of symptom onset. BMJ 2009, 338:b255.CrossRefPubMed
32.
Tyler KL: Prednisolone—but not antiviral drugs—improves outcome in patients with Bell’s palsy. Nat Clin Pract Neurol 2009, 5(2):74–75.CrossRefPubMed
33.
Davenport RJ, Sullivan F, Smith B, et al.: Treatment for Bell’s palsy. Lancet 2008, 372(9645):1219–1220; author reply 1220–1211.CrossRefPubMed
34.
Lockhart P, Daly F, Pitkethly M, et al.: Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2009, CD001869.
35.
Frueh BR, Preston RA, Musch DC: Facial nerve injury and hemifacial spasm. Am J Ophthalmol 1990, 110(4):421–423.PubMed
36.
Jordan DR, Patrinely JR, Anderson RL, Thiese SM: Essential blepharospasm and related dystonias. Surv Ophthalmol 1989, 34(2):123–132.CrossRefPubMed
37.
Cramer H, Otto K: Meige’s syndrome: clinical findings and therapeutic results in 50 patients. Neuroophthalmology 1986, 6(1):3–15.CrossRef
38.
Koutsis G, Kokotis P, Sarrigiannis P, et al.: Spastic paretic hemifacial contracture in multiple sclerosis: a neglected clinical and EMG entity. Mult Scler 2008, 14(7):927–932.CrossRefPubMed
39.
Andermann F, Lloydsmith DL, Gloor P, et al.: Facial myokimia in multiple sclerosis. Brain 1961, 84(1):31.CrossRef
40.
Tenser RB, Corbett JJ: Myokymia and facial contraction in brain stem glioma. An electromyographic study. Arch Neurol 1974, 30(6):425–427.PubMed
41.
Waybright EA, Gutmann L, Chou SM: Facial myokymia. Pathological features. Arch Neurol 1979, 36(4):244–245.PubMed
42.
Bettoni L, Bortone E, Ghizzoni P, Lechi A: Myokymia in the course of Bell’s palsy. An electromyographic study. J Neurol Sci 1988, 84(1):69–76.CrossRefPubMed
43.
Brackmann DE, Fetterman BL: Cranial nerve VII. In Textbook of Clinical Neurology. edn. 3. Edited by Goetz CG. Oxford, UK: Saunders Elsevier; 2003:1392.
Metadata
Title
Neuro-ophthalmologic Complications and Manifestations of Upper and Lower Motor Neuron Facial Paresis
Authors
M. Tariq Bhatti
Jade S. Schiffman
Anastas F. Pass
Rosa A. Tang
Publication date
01-11-2010
Publisher
Current Science Inc.
Published in
Current Neurology and Neuroscience Reports / Issue 6/2010
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-010-0143-1

Other articles of this Issue 6/2010

Current Neurology and Neuroscience Reports 6/2010 Go to the issue

ReviewPaper

Neurogenic Stuttering: Its Reticular Modulation

ReviewPaper

Rare Causes of Dystonia Parkinsonism

ReviewPaper

Ocular Motility of Aging and Dementia

ReviewPaper

The New Classification of Primary Progressive Aphasia into Semantic, Logopenic, or Nonfluent/Agrammatic Variants

ReviewPaper

Frontotemporal Dementia and Primary Progressive Aphasia: An Update

ReviewPaper

Biomarkers in Parkinson’s Disease